Voya Investment Management LLC Ngm Biopharmaceuticals Inc Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.44 - $4.53 $9,825 - $18,242	4,027 Added 25.85%	19,603 $50,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $13,572 - $19,048	1,078 Added 7.44%	15,576 $204,000
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $21,498 - $35,560	2,032 Added 16.3%	14,498 $186,000
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $3,572 - $4,558	207 Added 1.69%	12,466 $221,000
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $20,090 - $40,060	1,334 Added 12.21%	12,259 $242,000
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $11,670 - $14,911	467 Added 4.47%	10,925 $318,000
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $169,524 - $328,799	10,458 New	10,458 $317,000
Q2 2020 Aug 14, 2020	SELL	$11.97 - $23.47 $149,912 - $293,938	-12,524 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.0 - $19.51 $8,820 - $17,207	882 Added 7.58%	12,524 $154,000
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $116,070 - $236,099	11,642 New	11,642 $215,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.